These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32648459)

  • 1. Treatment response to intrathecal chemotherapy with pemetrexed via an Ommaya reservoir in EGFR-mutated leptomeningeal metastases from non-small cell lung cancer: a case report.
    Li H; Lin Y; Yu T; Xie Y; Feng J; Huang M; Guo A; Liu X; Yin Z
    Ann Palliat Med; 2020 Jul; 9(4):2341-2346. PubMed ID: 32648459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of Ommaya Reservoirs to Deliver Pemetrexed in Leptomeningeal Metastasis from Non-small Cell Lung Cancer: A Case Report and Review of the Literature].
    Lin Y; Li H; Huang M; Guo A; Yin Z
    Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):546-550. PubMed ID: 31451148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, Pharmacokinetic and Clinical Activity of Intrathecal Chemotherapy With Pemetrexed via the Ommaya Reservoir for Leptomeningeal Metastases From Lung Adenocarcinoma: A Prospective Phase I Study.
    Li H; Zheng S; Lin Y; Yu T; Xie Y; Jiang C; Liu X; Qian X; Yin Z
    Clin Lung Cancer; 2023 Mar; 24(2):e94-e104. PubMed ID: 36588048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erlotinib combined with bevacizumab and chemotherapy in first line osimertinib-resistant NSCLC patient with leptomeningeal metastasis: A case report.
    Wang M; Zhu F; Luo N; Li M; Qi Y; Wang M
    Medicine (Baltimore); 2021 Nov; 100(44):e27727. PubMed ID: 34871271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment using targeted therapy, radiotherapy, and intrathecal chemotherapy in a patient with leptomeningeal metastasis with an epidermal growth factor receptor exon 20 insertion mutation: a case report.
    Ma Y; Liu H; Zhang M; Liu B; Ding Q; Zhang L; Guo L; Liu M
    Ann Palliat Med; 2022 Apr; 11(4):1533-1541. PubMed ID: 34263612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete remission in leptomeningeal metastasis of NSCLC with rare EGFR-SEPT14 fusion treated with osimertinib combined with intrathecal chemotherapy with pemetrexed.
    Zheng S; Li H; Feng J; Jiang C; Lin Y; Xie Y; Yu T; Qian X; Yin Z
    Anticancer Drugs; 2022 Jan; 33(1):e795-e798. PubMed ID: 34486539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and their influences on the survival of leptomeningeal metastasis derived from lung adenocarcinoma harboring epithelial growth factor receptor mutation].
    Jiang AF; Zhou SS; Zhou Q; Zhao J; Li XP; Zhou RR; Li B
    Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(34):2713-2719. PubMed ID: 37675543
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis.
    Miao Q; Zheng X; Zhang L; Jiang K; Wu B; Lin G
    Ann Palliat Med; 2020 Nov; 9(6):4233-4245. PubMed ID: 33302683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial.
    Fan C; Jiang Z; Teng C; Song X; Li L; Shen W; Jiang Q; Huang D; Lv Y; Du L; Wang G; Hu Y; Man S; Zhang Z; Gao N; Wang F; Shi T; Xin T
    ESMO Open; 2024 Apr; 9(4):102384. PubMed ID: 38377785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor.
    Kwon BS; Cho YH; Yoon SK; Lee DH; Kim SW; Kwon DH; Lee JC; Choi CM
    Thorac Cancer; 2020 Feb; 11(2):436-442. PubMed ID: 31910497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer.
    Choi M; Keam B; Ock CY; Kim M; Kim TM; Kim DW; Heo DS
    Clin Lung Cancer; 2019 Jul; 20(4):e442-e451. PubMed ID: 31010639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era.
    Riess JW; Nagpal S; Iv M; Zeineh M; Gubens MA; Ramchandran K; Neal JW; Wakelee HA
    Clin Lung Cancer; 2014 May; 15(3):202-6. PubMed ID: 24524822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis.
    Yan W; Liu Y; Li J; Han A; Kong L; Yu J; Zhu H
    Radiat Oncol; 2019 Sep; 14(1):168. PubMed ID: 31521171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of Clinicopathological Feature and Prognosis for 
Leptomeningeal Metastasis in Non-small Cell Lung Cancer].
    Zhu M; Ren Y; Liu Y; Ban C; Gu H; Wang Z; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):533-8. PubMed ID: 27561804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis.
    Nie N; Zhou H; Zhang K; Liu L; Luo N; Wang R; Li X; Zhu M; Hu C; Wang Y; Liu Z; Li L; He Y
    Thorac Cancer; 2022 Sep; 13(18):2574-2583. PubMed ID: 35896160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases.
    Flippot R; Biondani P; Auclin E; Xiao D; Hendriks L; Le Rhun E; Leduc C; Beau-Faller M; Gervais R; Remon J; Adam J; Planchard D; Lavaud P; Naltet C; Caramella C; Le Pechoux C; Lacroix L; Gazzah A; Mezquita L; Besse B
    J Thorac Oncol; 2019 Aug; 14(8):1400-1407. PubMed ID: 31108248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer.
    Wu YL; Zhao Q; Deng L; Zhang Y; Zhou XJ; Li YY; Yu M; Zhou L; Zou BW; Lu Y; Liu YM
    Lung Cancer; 2019 Jan; 127():1-5. PubMed ID: 30642536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
    Yang H; Wen L; Pan Y; Shan C; Hong W; Wang H; Zhou C; Cai L; Zhou C
    BMC Cancer; 2022 May; 22(1):580. PubMed ID: 35614407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis.
    Chiang CL; Lee CC; Huang HC; Wu CH; Yeh YC; Shen CI; Luo YH; Shiao TH; Chang HJ; Huang YT; Chen YM; Chou TY; Chiu CH
    Target Oncol; 2021 Mar; 16(2):207-214. PubMed ID: 33566300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of Methods and Influencing Factors to Increase the Positive Rate of 
Cytological Pathology of Cerebrospinal Fluid from Lung Cancer Leptomeningeal Metastases].
    Gao N; Teng C; Fan C; Xin T
    Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):789-796. PubMed ID: 36419392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.